Neurology and Neuropsychiatry
February 17-18, 2025 | Amsterdam, Netherlands
Venue: Park Plaza Amsterdam Airport | Theme: Brain and Mental Health: Navigating the Future of Neurology and Psychiatry
2nd European Congress of Neurology and Neuropsychiatry – Conference Report
February 19-20, 2024, London UK
Day 1: February 19, 2024
The 2nd European Congress of Neurology and Neuropsychiatry commenced with enthusiasm and scholarly discussions at the heart of London, UK. The event brought together renowned neurologists, neuropsychiatrists, and researchers from diverse corners of the world.
The conference kicked off at 09:30 with a warm welcome by Dr. Allal Boutajangout from NYU Langone Health, USA. His opening remarks set the tone for the scientific feast that followed. The first keynote presentation, “Neural Population Computing Part 1,” unfolded the basic principles of population dynamics and cognitive function, presented by Dr. Stephen E Nadeau from the University of Florida, USA.
The morning continued with an intriguing exploration of plasma biomarkers in Alzheimer’s disease and COVID-19 subjects, eloquently discussed by Dr. Allal Boutajangout. The networking session before lunch provided an excellent opportunity for attendees to connect and share insights.
Post-lunch, Prof. Anand Pratap Singh from Gautam Buddha University, India, captivated the audience with his talk on “Exploring Psychopathology with Brain Fingerprinting Technique (BFT): A Paradigm Shift in Psychiatry.” The session continued with Dr. Gary Pattee from the University of Nebraska Medical Center, USA, delving into the intriguing question: “Is ALS Onset Accelerated by Chloroviruses and Delayed by Antiviral Immune Responses?”
The afternoon session unfolded diverse topics in the realm of Neurology and Neuropsychiatry, covering a rare case of pituitary dysfunction with Moyamoya disease, investigating molecular markers in treatment-resistant depression, and exploring the effectiveness of computer-assisted cognitive retraining among patients with mild cognitive impairment.
The day concluded with a series of impactful poster presentations, highlighting research on cognitive flexibility in experimental animals, depression and neuroplasticity, and unique case reports like late-onset Guillain Barré syndrome post-SARS-CoV-2 infection and acute psychosis with isotretinoin initiation.
The Q/A session provided a platform for engaging discussions, and the day culminated in an award ceremony, recognizing the contributions of speakers, delegates, and researchers.
Keynote Speakers:
Neurology Sessions:
European Congress of Neurology and Neuropsychiatry – Conference Report
March 6-7, 2023 – Canada
The European Congress of Neurology and Neuropsychiatry 2023 held on March 6th and 7th in Canada was a resounding success, bringing together a diverse and engaged audience of over 100 attendees, both physically and online. The event showcased the latest advancements and breakthroughs in the fields of neurology and neuropsychiatry and featured a remarkable lineup of speakers, mentors, and poster presentations. In conclusion, the European Congress of Neurology and Neuropsychiatry 2023 was a remarkable event that united experts, researchers, clinicians, and students from around the world. The engaging keynote speakers, diverse neurology sessions, insightful poster presentations, and successful mentorship program made this conference a pivotal platform for advancing the fields of neurology and neuropsychiatry.
Members from Top association attends Neurology 2023: